RankAlpha logo
Back to Rankings

HYFT

MindWalkD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
The bull case is that HYFT is beginning to convert AI-enabled discovery capabilities into recurring commercial revenue while still retaining upside from internally seeded biologics programs. Q3 showed third consecutive year-over-year growth, a first annual LensAI contract, and continued platform expansion into B Cell Llama, which together support a real if still early commercialization narrative [#6K-2026-03-12][#6K-2026-03-06].
Posture
Defensive
Lead driver
Sentiment
What changed
Next scheduled catalyst: earnings 2026-09-14 · AMC.
What can break
Low evidence quality and weak forward visibility despite active company messaging.
Momentum
79
Value
41
Sentiment
51
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.10 · Bull $2.00 · Bear $0.60Analysis 2026-04-15; returns require an exact persisted reference.
Earnings
2026-09-14 · AMC
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-11

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions

Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $4.40
Why
Momentum79 · Δ7d -
Value41 · Δ7d -0.0
Sentiment51 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • Next scheduled catalyst: earnings 2026-09-14 · AMC.
  • Sentiment remains the lead driver in the composite.

Contradictions & invalidation

  • Low evidence quality and weak forward visibility despite active company messaging.
  • Ongoing operating losses and a balance sheet that may require renewed financing or sharper burn discipline.
  • The bear case is that forward visibility is still weak: evidence quality is low, the company remains loss-making, and much of the pipeline story is still preclinical or strategic rather than externally validated.

Catalyst clock

2026-09-14 · AMC

Fiscal Q4 / year-end results should reset the liquidity and contract-conversion debate

Lead driver: Sentiment · See AI snapshot
Momentum
79
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
51
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade D. Momentum 79.0 / Value 41.2 / Sentiment 51.3

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-04-15. Scenario method

B+
Bull case
25%
Probability
Target price
$2.00
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
Most likely
B
Base case
45%
Probability
Target price
$1.10
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.60
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$62.49M
Beta
0.51
Shares Out
46.99M
P/E (TTM) · Derived
-6.1
P/S (TTM)
7.12
P/FCF (TTM) · Derived
-6.57
Rev YoY
+55.4%
EPS YoY
+81.9%
Gross Margin
+58.8%
Op Margin
-96.1%
Net Debt
-$5.75M
Current Ratio
2.80
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data